secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALTEROLA BIOTECH INC. (—)
CIK:        0001442999
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001663577-23-000511
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.02, 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alterola Biotech converts $2.35M debt to equity; replaces auditor Gries with GreenGrowth CPAs
--------------------------------------------------------------------------------

- Three holders converted $2.35M of debt into common shares at $0.004/share; issuance exempt under Section 4(2)/Reg D.
- Dismissed Gries & Associates after it sold its business; engaged GreenGrowth CPAs as new independent accountant.
- No disagreements with former auditor; prior reports contained going-concern qualification and material weaknesses in internal controls.
- Debt conversion significantly dilutes existing shareholders; no additional cash proceeds to the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1442999/000166357723000511/0001663577-23-000511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1442999/000166357723000511/abti8k101623.htm
  HTML page:      https://secwatch.observer/filing/0001663577-23-000511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer